Immunoglobulin cleavage enzymes

IdeSORK2.0, a novel polypeptide from Streptococcus kroesus, addresses the limitations of IdeS and IdeZ by efficiently cleaving human IgG, providing a therapeutic solution for autoimmune diseases and IgG-mediated conditions without inducing anti-drug antibodies.

JP7873677B2Active Publication Date: 2026-06-12ジェノヴィス アーベー
View PDF 10 Cites 0 Cited by

Patent Information

Application Number
JP2023565188
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-04-22
Filing Date
2022-04-22
Publication Date
2026-06-12
Estimated Expiration
2042-04-22

AI Technical Summary

Technical Problem

Existing immunoglobulin-cleaving enzymes like IdeS are pathogenic and induce anti-drug antibodies, limiting their therapeutic use, while non-human counterparts like IdeZ have reduced activity against human IgG.

Method used

Identification and characterization of a novel polypeptide, IdeSORK2.0, from Streptococcus kroesus, with enhanced expression and immunoglobulin cleavage activity, minimizing pre-existing immunity in humans.

Benefits of technology

IdeSORK2.0 effectively cleaves human IgG into Fc and F(ab')2 fragments, offering therapeutic potential without inducing anti-drug antibodies, thus treating autoimmune diseases and IgG-mediated conditions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007873677000011
    Figure 0007873677000011
  • Figure 0007873677000012
    Figure 0007873677000012
  • Figure 0007873677000013
    Figure 0007873677000013
Patent Text Reader

Abstract

The present invention relates to novel polypeptides that exhibit protease activity against immunoglobulins, particularly human IgG, and their uses in vivo, in vitro and ex vivo. Uses of said polypeptides include methods for the analysis of IgG and the generation of antibody fragments, as well as methods for the prevention or treatment of IgG-mediated diseases and conditions. The inventors have identified, purified and characterized a novel polypeptide. The polypeptide was identified in a previously unknown Streptococcus species that was isolated as part of studies in multiple rodents.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Method for analyzing an immunoglobulin molecule sample

    JP2016531546A

  • Cysteine ​​protease

    JP2018510622A

  • Compositions and methods relating to multimodal therapeutic cell lines for cancer indications

    JP2019501654A

  • protein

    WO2003051914A2

  • Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection

    WO2006131347A2